The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production
Open accessAbstract
Acute exacerbations are the major cause of asthma morbidity, mortality, and health-care costs and are difficult to treat and prevent. The majority of asthma exacerbations are associated with rhinovirus (RV) infection, but evidence supporting a causal relationship is weak and mechanisms are poorly understood. We hypothesized that in asthmatic, but not normal, subjects RV infection would induce clinical, physiologic, and pathologic lower airway responses typical of an asthma exacerbation and that these changes would be related to virus replication and impaired T helper 1 (Th1)/IL-10 or augmented Th2 immune responses. We investigated physiologic, virologic, and immunopathologic responses to experimental RV infection in blood, induced sputum, and bronchial lavage in 10 asthmatic and 15 normal volunteers. RV infection induced significantly greater lower respiratory symptoms and lung function impairment and increases in bronchial hyperreactivity and eosinophilic lower airway inflammation in asthmatic compared with normal subjects. In asthmatic, but not normal, subjects virus load was significantly related to lower respiratory symptoms, bronchial hyperreactivity, and reductions in blood total and CD8 + lymphocytes; lung function impairment was significantly related to neutrophilic and eosinophilic lower airway inflammation. The same virologic and clinical outcomes were strongly related to deficient IFN-γ and IL-10 responses and to augmented IL-4, IL-5, and IL-13 responses. This study demonstrates increased RV-induced clinical illness severity in asthmatic compared with normal subjects, provides evidence of strong relationships between virus load, lower airway virus-induced inflammation and asthma exacerbation severity, and indicates augmented Th2 or impaired Th1 or IL-10 immunity are likely important mechanisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Community study of role of viral infections in exacerbations of asthma in 9–11 year old children
Johnston, S. L., Pattemore, P. K., Sanderson, G., Smith, S., Lampe, F., Josephs, L., Symington, P., Toole, S. O., Myint, S. H., Tyrrell, D. A. J., et al. (1995) · BMJ · doi:10.1136/bmj.310.6989.1225 · Cited by 1,991 · cited 1×
“Virus infections are associated with 80–85% of pediatric (8, 9) and 75% of adult (10, 11) asthma exacerbations, and rhinoviruses (RVs) account for two-thirds of virus detections.”
BackgroundSelf-citationEffect of Inhaled Formoterol and Budesonide on Exacerbations of Asthma
Pauwels, R. A., Löfdahl, C.-G., Postma, D. S., Tattersfield, A. E., O'Byrne, P., Barnes, P. J., & Ullman, A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711133372001 · Cited by 1,520
Wark, P. A. B., Johnston, S. L., Bucchieri, F., Powell, R., Puddicombe, S., Laza-Stanca, V., Holgate, S. T., & Davies, D. E. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041901 · Cited by 1,235
Self-citationRole of deficient type III interferon-λ production in asthma exacerbations
Contoli, M., Message, S. D., Laza-Stanca, V., Edwards, M. R., Wark, P. A. B., Bartlett, N. W., Kebadze, T., Mallia, P., Stanciu, L. A., Parker, H. L., et al. (2006) · Nature Medicine · doi:10.1038/nm1462 · Cited by 1,006
Self-citationEffect of Inhaled Formoterol and Budesonide on Exacerbations of Asthma
(1998) · New England Journal of Medicine · doi:10.1056/nejm199801083380222 · Cited by 864
Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial
Pauwels, R. A., Pedersen, S., Busse, W. W., Tan, W. C., Chen, Y.-Z., Ohlsson, S. V., Ullman, A., Lamm, C. J., & O'Byrne, P. M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12891-7 · Cited by 763
Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma
Hawrylowicz, C. M., & O'Garra, A. (2005) · Nature Reviews Immunology · doi:10.1038/nri1589 · Cited by 683
Corne, J. M., Marshall, C., Smith, S., Schreiber, J., Sanderson, G., Holgate, S. T., & Johnston, S. L. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07953-9 · Cited by 573
Self-citationThe health economics of asthma and rhinitis. I. Assessing the economic impact
Weiss, K. B., & Sullivan, S. D. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.112262 · Cited by 543
Lemanske, R. F., Dick, E. C., Swenson, C. A., Vrtis, R. F., & Busse, W. W. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113843 · Cited by 413
Cited by
A summary of the new GINA strategy: a roadmap to asthma control
Reddel, H. K., Bateman, E. D., Becker, A., Boulet, L.-P., Cruz, A. A., Drazen, J. M., Haahtela, T., Hurd, S. S., Inoue, H., de Jongste, J. C., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.00853-2015 · Cited by 788
Role of viral respiratory infections in asthma and asthma exacerbations
Busse, W. W., Lemanske, R. F., & Gern, J. E. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61380-3 · Cited by 750
Jacobs, S. E., Lamson, D. M., St. George, K., & Walsh, T. J. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00077-12 · Cited by 704
The airway epithelium: soldier in the fight against respiratory viruses
Vareille, M., Kieninger, E., Edwards, M. R., & Regamey, N. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00014-10 · Cited by 655
IL-33–Dependent Type 2 Inflammation during Rhinovirus-induced Asthma Exacerbations In Vivo
Jackson, D. J., Makrinioti, H., Rana, B. M. J., Shamji, B. W. H., Trujillo-Torralbo, M.-B., Footitt, J., del-Rosario, J., Telcian, A. G., Nikonova, A., Zhu, J., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201406-1039oc · Cited by 573
Self-citationNeutrophilic Inflammation in Asthma and Association with Disease Severity
Ray, A., & Kolls, J. K. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.07.003 · Cited by 546
Asthma Exacerbations: Pathogenesis, Prevention, and Treatment
Castillo, J. R., Peters, S. P., & Busse, W. W. (2017) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2017.05.001 · Cited by 544
Martinez, F. D., & Vercelli, D. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61536-6 · Cited by 496
Mallia, P., Message, S. D., Gielen, V., Contoli, M., Gray, K., Kebadze, T., Aniscenko, J., Laza-Stanca, V., Edwards, M. R., Slater, L., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201006-0833oc · Cited by 415
Self-citationThe sentinel role of the airway epithelium in asthma pathogenesis
Holgate, S. T. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01030.x · Cited by 411
Al-Muhsen, S., Johnson, J. R., & Hamid, Q. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.04.047 · Cited by 408
Targeting the NF-κB pathway in asthma and chronic obstructive pulmonary disease
Edwards, M. R., Bartlett, N. W., Clarke, D., Birrell, M., Belvisi, M., & Johnston, S. L. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.09.003 · Cited by 375
“…individuals therefore have all the cellular hallmarks one would expect from the production of the above mediators, and commonly feature increased levels of airway eosinophils, neutrophils, and lymphocytes (Fraenkel et al., 1995; Grunberg et al., 1997; Pizzichini et al., 1998; Message et al., 2008).”
BackgroundInfluentialSelf-citationLloyd, C. M., & Hawrylowicz, C. M. (2009) · Immunity · doi:10.1016/j.immuni.2009.08.007 · Cited by 356
The role of viruses in acute exacerbations of asthma
Jackson, D. J., & Johnston, S. L. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.04.021 · Cited by 351
“Increases in airway hyperresponsiveness and decreases in both peak expiratory flow and FEV1 were demonstrated in asthmatic subjects without any change in these measures in healthy subjects.(9) This study, along with several others, supports the idea that respiratory tract viral infections cause a greater degree of mor…”
BackgroundResultSelf-citationAsthma exacerbations: Origin, effect, and prevention
Jackson, D. J., Sykes, A., Mallia, P., & Johnston, S. L. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.10.024 · Cited by 343
Self-citationBeale, J., Jayaraman, A., Jackson, D. J., Macintyre, J. D. R., Edwards, M. R., Walton, R. P., Zhu, J., Ching, Y. M., Shamji, B., Edwards, M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009124 · Cited by 332
“Mary’s Hospital, London, in accordance with standard guidelines (11).”
BackgroundMethodInfluentialSelf-citationHost DNA released by NETosis promotes rhinovirus-induced type-2 allergic asthma exacerbation
Toussaint, M., Jackson, D. J., Swieboda, D., Guedán, A., Tsourouktsoglou, T.-D., Ching, Y. M., Radermecker, C., Makrinioti, H., Aniscenko, J., Bartlett, N. W., et al. (2017) · Nature Medicine · doi:10.1038/nm.4332 · Cited by 319
Self-citationSlater, L., Bartlett, N. W., Haas, J. J., Zhu, J., Message, S. D., Walton, R. P., Sykes, A., Dahdaleh, S., Clarke, D. L., Belvisi, M. G., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001178 · Cited by 317
Self-citationMallia, P., Footitt, J., Sotero, R., Jepson, A., Contoli, M., Trujillo-Torralbo, M.-B., Kebadze, T., Aniscenko, J., Oleszkiewicz, G., Gray, K., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201205-0806oc · Cited by 274
Self-citationAsthma phenotypes and IgE responses
Froidure, A., Mouthuy, J., Durham, S. R., Chanez, P., Sibille, Y., & Pilette, C. (2016) · European Respiratory Journal · doi:10.1183/13993003.01824-2014 · Cited by 267
Impaired innate interferon induction in severe therapy resistant atopic asthmatic children
Edwards, M. R., Regamey, N., Vareille, M., Kieninger, E., Gupta, A., Shoemark, A., Saglani, S., Sykes, A., Macintyre, J., Davies, J., et al. (2013) · Mucosal Immunology · doi:10.1038/mi.2012.118 · Cited by 214
Self-citationEdwards, M. R., Bartlett, N. W., Hussell, T., Openshaw, P., & Johnston, S. L. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2801 · Cited by 205
Self-citationJuhn, Y. J. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.04.024 · Cited by 142
Design, recruitment, and microbiological considerations in human challenge studies
Darton, T. C., Blohmke, C. J., Moorthy, V. S., Altmann, D. M., Hayden, F. G., Clutterbuck, E. A., Levine, M. M., Hill, A. V. S., & Pollard, A. J. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00068-7 · Cited by 130
EAACI position statement on asthma exacerbations and severe asthma
Custovic, A., Johnston, S. L., Pavord, I., Gaga, M., Fabbri, L., Bel, E. H., Le Souëf, P., Lötvall, J., Demoly, P., Akdis, C. A., et al. (2013) · Allergy · doi:10.1111/all.12275 · Cited by 127
Self-citationBellinghausen, C., Gulraiz, F., Heinzmann, A. C. A., Dentener, M. A., Savelkoul, P. H. M., Wouters, E. F., Rohde, G. G., & Stassen, F. R. (2016) · Respiratory Research · doi:10.1186/s12931-016-0382-z · Cited by 71
Edwards, M. R., Saglani, S., Schwarze, J., Skevaki, C., Smith, J. A., Ainsworth, B., Almond, M., Andreakos, E., Belvisi, M. G., Chung, K. F., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.02448-2016 · Cited by 55
Self-citationDaniłowicz-Luebert, E., Steinfelder, S., Kühl, A. A., Drozdenko, G., Lucius, R., Worm, M., Hamelmann, E., & Hartmann, S. (2013) · International Journal for Parasitology · doi:10.1016/j.ijpara.2012.10.014 · Cited by 52
Altman, M. C., Beigelman, A., Ciaccio, C., Gern, J. E., Heymann, P. W., Jackson, D. J., Kennedy, J. L., Kloepfer, K., Lemanske, R. F., McWilliams, L. M., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.12.904 · Cited by 37
Metadata
- Authors
- Message, S. D., Laza-Stanca, V., Mallia, P., Parker, H. L., Zhu, J., Kebadze, T., Contoli, M., Sanderson, G., Kon, O. M., Papi, A., Jeffery, P. K., Stanciu, L. A., & Johnston, S. L.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2008-09-09
- Volume
- 105
- Issue
- 36
- Pages
- 13562-13567
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2108236415
- Cited by
- 487
- References
- 30
- FWCI
- 17.69
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.